Package 45802-141-67

Brand: ciclopirox

Generic: ciclopirox
NDC Package

Package Facts

Identity

Package NDC 45802-141-67
Digits Only 4580214167
Product NDC 45802-141
Product ID 45802-141_d75239bb-7620-45a8-9c3b-a41e4baa48dc
Description

1 BOTTLE, WITH APPLICATOR in 1 CARTON (45802-141-67) / 6.6 mL in 1 BOTTLE, WITH APPLICATOR

Marketing

Marketing Status
Marketed Since 2007-09-19
Brand ciclopirox
Generic ciclopirox
Sample Package No

Linked Drug Pages (1)

Ciclopirox ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TOPICAL"], "spl_id": "d75239bb-7620-45a8-9c3b-a41e4baa48dc", "openfda": {"nui": ["N0000008577", "N0000008841", "N0000008853", "N0000000150"], "unii": ["19W019ZDRJ"], "rxcui": ["309291"], "spl_set_id": ["02f46b6e-b424-4210-83bf-e79618df4344"], "pharm_class_pe": ["Decreased DNA Replication [PE]", "Decreased Protein Synthesis [PE]", "Decreased RNA Replication [PE]"], "pharm_class_moa": ["Protein Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, WITH APPLICATOR in 1 CARTON (45802-141-67)  / 6.6 mL in 1 BOTTLE, WITH APPLICATOR", "package_ndc": "45802-141-67", "marketing_start_date": "20070919"}], "brand_name": "Ciclopirox", "product_id": "45802-141_d75239bb-7620-45a8-9c3b-a41e4baa48dc", "dosage_form": "SOLUTION", "pharm_class": ["Decreased DNA Replication [PE]", "Decreased Protein Synthesis [PE]", "Decreased RNA Replication [PE]", "Protein Synthesis Inhibitors [MoA]"], "product_ndc": "45802-141", "generic_name": "Ciclopirox", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ciclopirox", "active_ingredients": [{"name": "CICLOPIROX", "strength": "80 mg/mL"}], "application_number": "ANDA077623", "marketing_category": "ANDA", "marketing_start_date": "20070919", "listing_expiration_date": "20261231"}